-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Jun Liu et al.
- excerpt from article chapter
【Ref: Liu J, et al.
Research Background
Glioblastoma (GBM) has a poor prognosis with an overall 5-year survival rate of less than 4%
The authors first employed a genome-wide RNAi screen to identify genes that regulate the survival and differentiation of GSCs
Research result
Trajectory analysis of single-cell sequencing revealed that ZNF117 could regulate the differentiation of GSCs to the oligodendrocyte lineageTranscriptome analysis of ZNF117 knockout cells showed that ZNF117 regulates Notch signaling; pathway enrichment analysis suggested that Notch activity was down-regulated in ZNF117 knockout cells
This study revealed that ZNF117, as a regulator of GSCs differentiation, could be a target for GBM therapy